Why is HABA Laboratories, Inc. ?
1
Poor Management Efficiency with a low ROE of 1.63%
- The company has been able to generate a Return on Equity (avg) of 1.63% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -8.07% and Operating profit at -21.66% over the last 5 years
3
Positive results in Dec 25
- NET PROFIT(9M) At JPY 318.56 MM has Grown at 51.69%
- ROCE(HY) Highest at 7.63%
- DEBT-EQUITY RATIO (HY) Lowest at -36.98 %
4
With ROE of 6.56%, it has a very attractive valuation with a 0.76 Price to Book Value
- Over the past year, while the stock has generated a return of -3.33%, its profits have risen by 207.4% ; the PEG ratio of the company is 0.1
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -3.33% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to HABA Laboratories, Inc. should be less than 10%
- Overall Portfolio exposure to FMCG should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is HABA Laboratories, Inc. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
HABA Laboratories, Inc.
-100.0%
-0.69
16.51%
Japan Nikkei 225
38.94%
1.30
28.24%
Quality key factors
Factor
Value
Sales Growth (5y)
-8.07%
EBIT Growth (5y)
-21.66%
EBIT to Interest (avg)
-19.43
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
1.10
Tax Ratio
9.31%
Dividend Payout Ratio
26.23%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.41%
ROE (avg)
1.63%
Valuation Key Factors 
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
0.76
EV to EBIT
6.52
EV to EBITDA
5.13
EV to Capital Employed
0.64
EV to Sales
0.32
PEG Ratio
0.06
Dividend Yield
NA
ROCE (Latest)
9.82%
ROE (Latest)
6.56%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Mildly Bullish
Technical Movement
7What is working for the Company
NET PROFIT(9M)
At JPY 318.56 MM has Grown at 51.69%
ROCE(HY)
Highest at 7.63%
DEBT-EQUITY RATIO
(HY)
Lowest at -36.98 %
INVENTORY TURNOVER RATIO(HY)
Highest at 1.27 times
-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 10.86 times
NET PROFIT(Q)
At JPY 130.59 MM has Fallen at -32.11%
Here's what is working for HABA Laboratories, Inc.
Debt-Equity Ratio
Lowest at -36.98 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Inventory Turnover Ratio
Highest at 1.27 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Here's what is not working for HABA Laboratories, Inc.
Net Profit
At JPY 130.59 MM has Fallen at -32.11%
over average net sales of the previous four periods of JPY 192.34 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
Debtors Turnover Ratio
Lowest at 10.86 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






